Previous 10 | Next 10 |
2024-04-23 07:01:46 ET The company's financial performance has been impacted by market fluctuations and technological innovations, with revenue growth varying unpredictably. Management is focused on developing new products and services while monitoring industry changes and AI uncertainties. K...
2024-04-23 06:02:02 ET More on Danaher Danaher: All In On Life Sciences, And Market Update Danaher Corporation (DHR) TD Cowen 44th Annual Health Care Conference (Transcript) Danaher: Better Positioned For The Future Danaher Q1 2024 Earnings Preview Da...
Danaher Reports First Quarter 2024 Results PR Newswire WASHINGTON , April 23, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended March 29 , 2024. All results in this release reflect only continuing...
2024-04-22 13:45:17 ET More on Danaher Danaher: All In On Life Sciences, And Market Update Danaher Corporation (DHR) TD Cowen 44th Annual Health Care Conference (Transcript) Danaher: Better Positioned For The Future Danaher sees another year of contraction as...
2024-04-20 12:03:00 ET Summary abrdn Healthcare Opportunities Fund (THQ) offers a high dividend yield of 11.3% and exposure to diverse subsectors of the healthcare industry. The fund outperforms its peers, abrdn World Healthcare Fund (THW) and BlackRock's Health Sciences Trust (BM...
2024-04-20 09:53:05 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The D...
2024-04-20 09:10:00 ET Summary IDEX is not well-known is because it sells decidedly mundane, typically niche parts and technology. We believe, however, that IDEX is among a class of companies that can outperform via acquisitions. IDEX has proven its ability to generate attract...
2024-04-18 09:15:00 ET Summary The Ensemble Fund seeks to achieve long-term capital appreciation. The Fund invests in a focused portfolio of approximately 15 to 30 securities that meet our demanding criteria. After outperforming the market handily in the previous quarter, the fund...
2024-04-18 07:00:00 ET Summary Short-term bonds currently yield more than stocks, indicating a shift in the investment environment. Investors should focus on companies with healthy balance sheets, pricing power, and that are trading below their fair value. We suggest several f...
2024-04-17 16:28:18 ET More on AdaptHealth AdaptHealth Corp. (AHCO) Q4 2023 Earnings Call Transcript AdaptHealth GAAP EPS of -$1.91 misses by $2.07, revenue of $858.2M beats by $32.75M Seeking Alpha’s Quant Rating on AdaptHealth Historical earnings dat...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 10:45:04 ET Pacific Biosciences of California Inc (PACB) PACB is trading UP for the last 5 days, and it at trading at $2.10 with volume of 3,952,245 and a one day change of $0.19 (9.97%). Pacific Biosciences of California Inc has a 52-week low of 1.16 and a 52-week high o...
Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration PR Newswire BREA, Calif. , July 25, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the Dx...
2024-07-23 20:30:03 ET Goldman Sachs analyst issues NEUTRAL recommendation for DHR on July 23, 2024 06:19PM ET. The previous analyst recommendation was Neutral. DHR was trading at $264.18 at issue of the analyst recommendation. The overall analyst consensus : BUY. Cu...